Altuviiio Shows Sustained Protection Against Bleeding Episodes in Children with Severe Hemophilia A
July 18th 2024Altuviiio is a first-in-class, high-sustained factor VIII replacement therapy, indicated for routine prophylaxis and on-demand treatment to control bleeding episodes in adults and children with hemophilia.
Real–World Data Show Efficacy of Beyfortus Against Hospitalization for RSV-Associated Bronchiolitis
July 11th 2024Study findings suggest that campaigns starting each year at the beginning of respiratory syncytial virus outbreaks, instead of continuous treatment of newborns throughout the year, may improve the usefulness of the Beyfortus program.
Dupixent Associated With Reduced Exacerbations, Improved Lung Function in Patients with COPD
July 9th 2024Phase III NOTUS trial data show patients with chronic obstructive pulmonary disease and type 2 inflammation administered Dupixent experienced reduced exacerbations and superior lung function compared to placebo.